Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression of the P16 Protein in Serous Papillary Endometrial Cancer, and Its Clinical and Prognostic Significance

NCT01267357 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT01267357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01267357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression of the P16 Protein in Serous Papillary Endometrial Cancer, and Its Clinical and Prognostic Significance
Lead sponsor
Rambam Health Care Campus
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
Not reported
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

serous papillary endometrial cancer